New drug approvals hit 21-year high in 2017
LONDON (Reuters) - U.S. drug approvals hit a 21-year high in 2017, with 46 novel medicines winning a green light -- more than double the previous year -- while the figure also rose in the European Union.
from Reuters: Health News http://reut.rs/2CemW6F
http://bit.ly/2zwRqiM